Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market Size By Type (X-Ray, MRI), By Application (Hospitals, Imaging Centers), By Region, And Segment Forecasts, 20...

The Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market was valued at USD 428 million in 2023 and is projected to reach USD 716 million by 2031, growing at a CAGR of 6.5% during the forecast period from 2023 to 2031. BRIC is a rare liver disorder that demands specialized diagnostic approaches to detect episodic cholestasis without permanent liver damage. As awareness of rare hepatic diseases increases and diagnostic imaging technology continues to evolve, demand for targeted imaging modalities—such as MRCP (Magnetic Resonance Cholangiopancreatography), ultrasound elastography, and hepatobiliary scintigraphy—is expected to grow significantly.

Drivers:

1. Increasing Incidence of Liver-Related Disorders:

Although BRIC is a rare condition, the overall rise in liver disease awareness and the increasing number of hepatology referrals have enhanced early diagnosis rates, boosting the demand for specialized imaging equipment.

2. Technological Advancements in Diagnostic Imaging:

Modern imaging modalities such as MRI-based liver function assessment and contrast-enhanced ultrasound provide more accurate detection and differentiation of BRIC from other cholestatic conditions, driving equipment adoption.

3. Growth in Rare Disease Registries and Research Funding:

Increased global attention toward rare diseases through registries and government-backed research initiatives is contributing to higher demand for precise diagnostic tools and specialized imaging platforms.

Restraints:

1. High Cost of Advanced Imaging Modalities:

The high acquisition and maintenance costs of sophisticated diagnostic equipment like MRCP and PET-MRI scanners pose a challenge, particularly in developing economies.

2. Limited Awareness and Access in Developing Regions:

Due to the rarity of BRIC and the limited access to advanced hepatology centers in low- and middle-income countries, the market remains underserved in several geographies.

Opportunity:

1. Integration of AI in Imaging Platforms:

Artificial intelligence and machine learning algorithms can significantly enhance diagnostic accuracy by improving liver lesion detection and aiding in differential diagnosis, opening new frontiers in BRIC detection.

2. Expansion of Tele-Radiology and Remote Diagnosis Services:

Emerging telemedicine networks and global health collaborations are enabling access to diagnostic services in remote areas, improving BRIC detection rates and expanding market reach.

Market by System Type Insights:

The MRCP-based Imaging Equipment segment accounted for the largest market share in 2023. This modality is preferred due to its non-invasive nature, high-resolution visualization of the biliary tree, and its effectiveness in identifying intermittent episodes of cholestasis. The segment is expected to maintain its lead, supported by continuous innovations in magnetic resonance technologies and contrast agents.

Ultrasound-based diagnostic tools, particularly elastography, are expected to witness strong growth due to their affordability and efficiency in liver stiffness measurement and bile duct visualization in real-time.

Market by End-use Insights:

In 2023, the Hospital Diagnostic Centers segment dominated the market, capturing over 50% of the revenue share. Hospitals remain the primary access points for BRIC diagnosis, given the requirement for multi-modal imaging and expert evaluation.

Specialty Imaging Clinics are projected to grow rapidly due to increasing investments in advanced diagnostic tools and the emergence of outpatient hepatology services in urban areas.

Market by Regional Insights:

North America led the global BRIC diagnostic imaging equipment market in 2023, attributed to its robust healthcare infrastructure, high adoption of cutting-edge imaging technologies, and strong presence of medical device manufacturers.

Asia-Pacific is expected to witness the highest CAGR during the forecast period. Improved healthcare funding, rising awareness of liver disorders, and increasing investment in diagnostic infrastructure—especially in China and India—are accelerating growth in the region.

Competitive Scenario:

Key players in the Global BRIC Diagnostic Imaging Equipment Market include Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, Fujifilm Holdings Corporation, Hologic Inc., and Esaote SpA. These companies are focusing on technological innovations, regulatory approvals, and strategic partnerships to expand their market footprint.

Key Developments Include:

2023: Siemens Healthineers launched a high-resolution MRCP imaging upgrade with AI-enhanced lesion detection features.

2024: GE Healthcare partnered with academic institutions to develop a liver-specific imaging AI suite.

2025: Philips Healthcare expanded its presence in Asia by setting up a dedicated hepatology diagnostic imaging R&D center.

Scope of Work – Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market

Report Metric Details

Market Size (2023) USD 428 million

Projected Market Size (2031) USD 716 million

CAGR (2023–2031) 6.5%

Market Segments By System Type (MRCP, Ultrasound, PET-MRI), By End-use (Hospitals, Specialty Imaging Clinics)

Growth Drivers Increasing liver disease diagnoses, advances in imaging technology, rare disease awareness

Opportunities AI integration in imaging, tele-radiology expansion

Key Market Developments:

July 2023: Canon Medical introduced AI-powered liver mapping software compatible with MRCP systems.

March 2024: Hologic Inc. announced FDA clearance for a multi-modal liver diagnostic platform for rare hepatic diseases.

January 2025: Esaote SpA launched a portable ultrasound scanner with liver-focused pre-sets for rural and outreach clinics.

FAQs:

1) What is the current market size of the Global Benign Recurrent Intrahepatic Cholestasis (BRIC) Diagnostic Imaging Equipment Market?

The market size was valued at USD 428 million in 2023.

2) What is the major growth driver of the Global BRIC Diagnostic Imaging Equipment Market?

The primary driver is the rising demand for advanced imaging solutions to diagnose rare liver diseases accurately.

3) Which is the largest region during the forecast period in the Global BRIC Diagnostic Imaging Equipment Market?

North America is the largest region, owing to its advanced healthcare infrastructure and adoption of modern imaging technologies.

4) Which segment accounted for the largest market share in the Global BRIC Diagnostic Imaging Equipment Market?

The MRCP-based Imaging Equipment segment held the largest market share in 2023.

5) Who are the key market players in the Global BRIC Diagnostic Imaging Equipment Market?

Key players include Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, and Fujifilm Holdings Corporation.